NL-OMON42886已完成不适用
A 2-part, randomized, double-blind, placebo-controlled, sequential group, dose-escalation study to assess the safety, tolerability and pharmacokinetics of single and multiple ascending oral doses of GLPG2737 in healthy male sub. - GLPG2737 SAD and MAD study
Galapagos SAS0 个研究点目标入组 112 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy Males between 18-50 years of age, inclusive,
- •body mass index (BMI) between 18-30 kg/m2, inclusive
- •Non-smokers and non-users of any nicotine-containing products
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/Aids. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from start of the study. In case of donating more than 100 milliliters of blood in the 12 weeks prior start of this study.
研究者
相似试验
已完成
1 期
A 2-part, randomized, double-blind, placebo-controlled study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of FTP 198 in healthy volunteersRespiratory - Other respiratory disorders / diseasesIdiopathic pulmonary fibrosisACTRN12620000181909Avance Clinical75
已完成
1 期
A 2-part, randomised, double-blind, placebo-controlled study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of FTP 637 in healthy volunteers.PsoriasisSkin - Dermatological conditionsACTRN12621000011886Alumis Inc (formerly Esker Therapeutics, Inc)87
进行中（未招募）
1 期
A clinical trial to find out if VAY736 can help people with autoimmune hepatitis, a disease where your immune system attacks your own liverAutoimmune Hepatitis (AIH)MedDRA version: 20.0Level: PTClassification code 10003827Term: Autoimmune hepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2017-001555-32-ESovartis Farmacéutica S.A80
进行中（未招募）
1 期
A clinical trial to find out if VAY736 can help people with autoimmune hepatitis, a disease where your immune system attacks your own liverAutoimmune Hepatitis (AIH)MedDRA version: 20.1Level: PTClassification code 10003827Term: Autoimmune hepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2017-001555-32-DEovartis Pharma AG65
撤回
2 期
A two-part randomized, double-blind, placebo-controlled multicenter dose ranging and confirmatory study to assess the safety and efficacy of VAY736 in autoimmune hepatitis patients with incomplete response to or intolerance of standard therapy (AMBER)Autoimmun hepatitis10003816NL-OMON48945ovartis6